J&J Puts COVID-19 Vaccine Trials On Hold After Participant Reports Illness
Johnson & Johnson's clinical trials for a COVID-19 vaccine have been halted after an illness reported by one of the participants of the trial. Though the company has not revealed the exact nature of the illness, it has said that the illness is being reviewed by an independent board and their physicians. Experts opine that such incidents are common during the trials of a vaccine.